OpenAlex
Works that cite this article, indexed by OpenAlex.
An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications
Cell Death Discovery 9(1) (2023)
Yanan Jiang; Xiuyun Shen; Fengnan Zhi; Zhengchao Wen; Yang Gao; Juan Xu; Baofeng Yang; Yunlong Bai
Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities
Journal of Cancer Research and Clinical Oncology 149(4) (2022)
Mitra Zabihi; Ramin Lotfi; Amir‐Mohammad Yousefi; Davood Bashash
CDK9 inhibitors in multiple myeloma: a review of progress and perspectives
Medical Oncology 39(4) (2022)
Jędrzej Borowczak; Krzysztof Szczerbowski; Navid Ahmadi; Łukasz Szylberg
CDK12 inhibition upregulates ATG7 triggering autophagy via AKT/FOXO3 pathway and enhances anti-PD-1 efficacy in colorectal cancer
Pharmacological Research 201 (2024)
Zimei Wu; Wenxin Zhang; Lu Chen; Tianxiao Wang; Xinhai Wang; Huanying Shi; Liudi Zhang; Mingkang Zhong; Xiaojin Shi; Xiang Mao; Haifei Chen; Qunyi Li
Inhibition of Cyclin-dependent Kinase (CDK) Decreased Survival of NB4 Leukemic Cells: Proposing a p53-Independent Sensitivity of Leukemic Cells to Multi-CDKs Inhibitor AT7519.
PubMed 19(3) (2020)
Atieh Pourbagheri‐Sigaroodi; Ava Safaroghli‐Azar; Mehrnoosh Shanaki; Amir‐Mohammad Yousefi; Ali Anjam-Najmedini; Davood Bashash
Inhibitor of Multi-cyclin-dependent Kinases (AT7519) Reduced Survival of U937 Leukemic Cells and Enhanced Anti-leukemic Effect of Vincristine: A Highlight to CDK Inhibition Efficacy in Acute Leukemia
International Journal of Cancer Management 14(2) (2021)
Fateme Moradi Moraddahande; Mona Shameli Houjghan; Amir‐Mohammad Yousefi; Ava Safaroghli‐Azar; Atieh Pourbagheri‐Sigaroodi; Davood Bashash